A U.S. Food and Drug Administration advisory panel voted on Thursday in favor of expanding Alkermes’ alcohol addiction treatment drug, Vivitrol, to treat opioid addiction.
Continue reading Alkermes Opioid Addiction Drug Vivitrol Gains FDA Panel Support
Alkermes Opioid Addiction Drug Vivitrol Gains FDA Panel Support originally appeared on DailyFinance on Fri, 17 Sep 2010 06:30:00.
Filed Under: Health Care, Stocks in the News